Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Improving the metabolic fidelity of cancer models with a physiological cell culture medium.

Vande Voorde J, Ackermann T, Pfetzer N, Sumpton D, Mackay G, Kalna G, Nixon C, Blyth K, Gottlieb E, Tardito S.

Sci Adv. 2019 Jan 2;5(1):eaau7314. doi: 10.1126/sciadv.aau7314. eCollection 2019 Jan.

2.

TKTL1 expression in human malign and benign cell lines.

Kämmerer U, Gires O, Pfetzer N, Wiegering A, Klement RJ, Otto C.

BMC Cancer. 2015 Jun 10;15:2. doi: 10.1186/1471-2407-15-2.

3.

Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.

Jerby-Arnon L, Pfetzer N, Waldman YY, McGarry L, James D, Shanks E, Seashore-Ludlow B, Weinstock A, Geiger T, Clemons PA, Gottlieb E, Ruppin E.

Cell. 2014 Aug 28;158(5):1199-1209. doi: 10.1016/j.cell.2014.07.027.

4.

Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial.

Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U.

Nutr Metab (Lond). 2011 Jul 27;8(1):54. doi: 10.1186/1743-7075-8-54.

5.

Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.

Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R, Voelker HU, Thiede A, Coy JF.

BMC Cancer. 2008 Apr 30;8:122. doi: 10.1186/1471-2407-8-122.

Supplemental Content

Loading ...
Support Center